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Agelastatin A, isolated from the axinellid sponge Agelas dendromorpha of the Coral Sea, is a new-skeleton alkaloid 
with, unusually for the oroidin family to which it belongs, marked cytotoxicity toward tumour cells in culture. 
Initially isolated from the Mediterranean axinellid sponge 
AgeZm mo¿des,lQ oroidin 1 is historically the central exam- 
ple'b.2 in a series of similar alkaloids, like hymenidin 2,3 or the 
hypothesized precursor of dimerized,2 or 6,15,4 4,15-5,9,4b.5 
4,12-5,9,6 or 4,914,127.cyclized alkaloids isolated from marine 
sponges, mostly of the order Axinellida. Isolated from Agelar 
dendromorpha, we report here the novel alkaloid agelastatin 
A.3, which may be viewed to descend biogeneticallyfrom a 
hymenidin-like precursor along the new cyclization mode 
4,8-7,12. 
A .  dendromorpha, collected by dredging at Les Trois 
Bancs, -260 m, New Caledonia, was freeze-dried (12 g), 
extracted with EtOH, and partitioned between H20 and 
CH2C12. The aqueous layer was evaporated to give 2.6 g of 
residue, which was subjected to TLC to give agelastatin A 3 
(0.15 g, 1.2% on dry sponge residue)., which proved to be 
markedly cytotoxic.? 
Treatment of 3 with Me1 in dry KOH-Me2S0 led to the 
incorporation of three methyl groups, giving, after HPLC 
(Merck sido, CH2C12EtOH 97 : 3,s  ml min-1, fR = 12.8min) 
pure 4, the 13C and 1H NMR spectra of which, in combination 
with MS data,$ revealed the composition Cl5HI9BrN4O3 and 
the presence of four unsaturated bonds. Two of these were 
Me 
l ; R = B r  
2 ;ReH 
3;R=H 
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t 3, contaminated, as far as can be deduced from IH NMR spectra, by 
a few percent of the difficultly removable 13.14-dibromo analogue, 
proved to be powerfully cytotoxic toward KB cells in culture with 
ECm value between 0.5 and 0.1 pg ml-1 and. which is probably an 
expression Of the same property, to inhibit in v i m  the concanavaline 
A-(lymphocyte T) or LPS-induced (lymphocyte B) proliferation of 
murine spleen celk. 
$ Data for 4: [a]$ -84.3 (EtOH, c 0.3 g per 100 ml); W (EtOH) 
kax279 (11900), 232 (8400), 203 (12400); IR (KBr) 1700,1635,1550 
cm-l; I 3 c  NMR (75.43 MHZ;  CD30D) 6 (rel. to SiMe.,) 26.65 [s, 
Me-N(I)], 162.21 [s. C(2)]. 30.71 [q, Me-N(3)], 67.18 [d, C(4)], 98.41 
[s, C(5)]. 52.16 (4, OMe), 41.59 [t, C(6)], 55.12 [d, C(7)], 66.50 [d, 
C(8)], 33.06 [q, Me-N(9)], 161.97 [s. C(lO)], 125.70 [s, C(ll)], 108.03 
[s, C(13)], 115.72 [d, C(14)], 117.73 [d, C(15)I: 'H NMR (299.94 
M e ,  CD30D) 6 (SiMe,) 2.81 [s, Me-N(l)], 2.98 [s. Me-N(3)], 4.30 
[br.s, H(4)], 3.14 (s; MeO), 2.12 [br.t, Hg(6)J. 2.67 [br.dd, H,(6)], 
4.67 [m, W ) ] ,  4.24 [br.d. H(8)], 3.18 [s, Me-N(9)]. 6.33 [d, H(14)], 
6.89 [br.d, H(15)] (J values as for 3 in CD30D); EI-MS m/z 3841382 
(M+, 10.0110.5%), 303 ([M - Br]+, 68). 271 ([M - Br - MeOH]+, 
22). 228 (45). 125 (100); H E I - M S  mlz 382.063 t- 0.0025, calculated 
for CisHigN40379Br 382.064; 384.061 -1- 0.0027, calculated for 
Cl~H19N403~1Br 384.062. 
r- -- 
O 1 O00 1262 
revealed as a 1,4-disubstituted cisoid diene system from 
t yp id  coupling J = 4.2Hz, while the other two showed up as 
amide carbonyl groups from typical 6c-o values. Thus, 
agelastatin must be tetracyclic. 
From now on, NMR data for either 39 or 4S'ai.e used 
alternatively as most appropriate. Thus, conne-dvities C(6)- 
C(7)-C(8) were best supported 'with natural 3 by large 
interproton couplings, while C(6) could be connected to C(5)  
and the latter to C(4) on the basis, respectively, of 1H-13C 
correlation data and 10% nuclear Overhauser effect (NOE) at 
H-C(4) on irradiation at MeO. Closure of the cyclopentane 
ring was based on both 1H-J3C correlation between C(5) and 
H-C(8) and small (<OS Hz) Jcoupling between H(4) and H(8) 
with 3; for the latter the C(4)-N(1) fragment was also suggested 
by 1H-13C correlation within the couples H-N(3)-C(2), 
H-CQ-C2, and MeN(l)-;.C(2). The.ipidazolidone ring cpuld, 
be closed on the basis of large deshielding of C(5) in either 3 or 4 
(6 93-98), which demands bonding of C(5) to both O and N. 
The diene system, identified above, was extended to C(10)- 
N(9).on the basis of 1H-13C correlations between either C(10) 
and MeN(9) in 4, or C(11) and H-N(9) in3. The oxopyrazine- 
pyrrole system fused to the cyclopentane ring was based'both 
on. typical:pyrrole and.bromopyrrole 6, values for C(l1) and 
C(13);?.§ an& the observation of deshielded C(7) and C(8), 
which require bonding to N. This was further supported by 
selective INEPT (insensitive nuclei enhanced by polarisation 
transfer) irradiation at H(7) which brought about magnetiza- 
Scheme 1 
I Data for 3: 13C NMR (CD30D) 6 25.79 [q, MeN(l)], 163.od [S, 
C(2)J. 68.98 [d, C(4)], 97.24 [s, C(5)] 41.58 [t, C(6)], 55.96 [d, C(7)], 
63.76 [d, C(8)], 162.65 [s, C(lO)], 125.71 [s, C(ll)], 108.80[s. C(13)]. 
Me-N(l)], 158.58 [s, C(2)]* 65.02 [d, C(4)], 93.34 [s, C(5)], 38.93 [i, 
C(6)], 52.49 [d, C(7)], 60.25 [d, C(8)], 157.69 [s, C(lO)], 123.52 [s, 
C(ll)], 104.49 [s, C(13)], 111.83 [d, C(14)], 113.36 [d, C(15)l; '€3 
NMR (CD30D) 6 2.81 [s, Me-N(l)], 3.89 [br.s, J.@, 1 4 . 6 ~ .  J4.7 and 
14.8 < O S  Hz, H(4)], 2.10 [br.t,J,,, 12.9,J6ßa7 12.3,J~,~0.6,&.4 < O S  
Hz, Hb(6)], 2.65 [br.dd, Jgcm 12.9, Jha7 6.6, J&.B 0.9, J k . 4  c0.5 Hz, 
H,(6)], 4.60 [m, &.6ß 12.3, J 7 . k  6.6, J7.8 5.4, J7.4 and &.IS 4 . 5  Hz, 
H(7)],4.09 [br.d, J~.75.4.1~.~0.9,Je,6ß0.6.J8ct0.5Hz,H(8)],6.33 
[(CD&SO] 6 2.64 [s, Me-N(l)], 7.11 [d, J3.4 2.1 Hz, HN(3)], 3.77 
[br.d, J4.3 2.1 Hz, H(4)], 1.92 [br.t, Igcm 12.6, 168.7 12.0 Hz, H~(6)l. 
2.46 [br.dd, JE<,,, 12.6, 6.0 Hz, H,(6)], 4.36 [m, J7.6ß 12.0, J7.b 
6.0.J7.8 5.4 Hz, H(7)]. 3.96 [br.d, J8.7 5.4 Hz, H(8)], 8.02 [s, KN(9)], 
115.37 [d, C(14)], 117.59 [d, C(l5)l; [(CD&SO] 6 23.50 [q, 
[d. Ji4.15 4.2, H(14)], 6.92 [br-d, JI,,, 4.2, 115.7 C0.5 Hz, H(15)I; 
6.34 [d. J iq i5  4.2 Hz. H(14)], 6.74 [d, J1s.14 4.2 fi. H(15)I- 
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tion transfer to both C( 13) and C( ll), thus also establishing the 
position of Br. We based 4,s- and 7,8-ciF fusions on differential 
NOES within MeO---H(4) and H(7)---H(8), respectively, and 
4,8-trans fusion on small coupling between H(4) and H(8). 
Extensive differential NOE within the couples of protons 
MeN( 1) - -MeO, H(4) - - -MeN(3), H(4). -Me(9), H2(6). - -H(7), 
H(8).--MeN(3), and H(14)---H(15) with both 3 and 4 con- 
firmed these structural deductions. 
Biogenesis of agelastatin A may be imagined, as in Scheme 
1, from enzyme-driven C(8) attack at C(4) in hymenidin-like 
precursor 5 and pyrrole nitrogen attack at developing positive 
C(7), followed by re-functionalization at C(4) and C(5). 
Oroidm-family alkaloids have already shown antibac- 
terial,2.Q antifungal,2 antiserotonergic,3.s a-adrenoceptor 
bl0cking,~a,9 and mild cytotbxic~o activities. Agelastatin .A 
emerges in this family of alkaloids as the first example of 
markedly cytotoxic agent toward tumour cells. 
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